112 related articles for article (PubMed ID: 12829987)
41. Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon.
McCartney EM; Semendric L; Helbig KJ; Hinze S; Jones B; Weinman SA; Beard MR
J Infect Dis; 2008 Dec; 198(12):1766-75. PubMed ID: 18956976
[TBL] [Abstract][Full Text] [Related]
42. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.
Frese M; Schwärzle V; Barth K; Krieger N; Lohmann V; Mihm S; Haller O; Bartenschlager R
Hepatology; 2002 Mar; 35(3):694-703. PubMed ID: 11870386
[TBL] [Abstract][Full Text] [Related]
43. An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones.
Bruni R; Marcantonio C; Tritarelli E; Tataseo P; Stellacci E; Costantino A; Villano U; Battistini A; Ciccaglione AR
BMC Genomics; 2011 Oct; 12():485. PubMed ID: 21970718
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus.
Shen H; Yamashita A; Nakakoshi M; Yokoe H; Sudo M; Kasai H; Tanaka T; Fujimoto Y; Ikeda M; Kato N; Sakamoto N; Shindo H; Maekawa S; Enomoto N; Tsubuki M; Moriishi K
PLoS One; 2013; 8(12):e82299. PubMed ID: 24358168
[TBL] [Abstract][Full Text] [Related]
45. Impact of alcohol on hepatitis C virus replication and interferon signaling.
McCartney EM; Beard MR
World J Gastroenterol; 2010 Mar; 16(11):1337-43. PubMed ID: 20238400
[TBL] [Abstract][Full Text] [Related]
46. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model.
Perlemuter G; Lettéron P; Carnot F; Zavala F; Pessayre D; Nalpas B; Bréchot C
J Hepatol; 2003 Dec; 39(6):1020-7. PubMed ID: 14642621
[TBL] [Abstract][Full Text] [Related]
47. Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+.
Seronello S; Ito C; Wakita T; Choi J
J Biol Chem; 2010 Jan; 285(2):845-54. PubMed ID: 19910460
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C, innate immunity and alcohol: friends or foes?
Osna NA; Ganesan M; Kharbanda KK
Biomolecules; 2015 Feb; 5(1):76-94. PubMed ID: 25664450
[TBL] [Abstract][Full Text] [Related]
49. Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.
Takeshita S; Ichikawa T; Taura N; Miyaaki H; Matsuzaki T; Otani M; Muraoka T; Akiyama M; Miuma S; Ozawa E; Ikeda M; Kato N; Isomoto H; Takeshima F; Nakao K
J Gastroenterol; 2012 Feb; 47(2):195-202. PubMed ID: 22038554
[TBL] [Abstract][Full Text] [Related]
50. Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression.
Lin CK; Tseng CK; Chen KH; Wu SH; Liaw CC; Lee JC
Br J Pharmacol; 2015 Sep; 172(18):4481-4492. PubMed ID: 26102077
[TBL] [Abstract][Full Text] [Related]
51. Alcohol-drug interactions.
FDA Drug Bull; 1979 Jun; 9(2):10-2. PubMed ID: 38165
[No Abstract] [Full Text] [Related]
52. [Lifecycle of HCV and point of action of the anti-HCV drugs].
Matsuura Y
Nihon Rinsho; 2015 Feb; 73(2):184-8. PubMed ID: 25764668
[No Abstract] [Full Text] [Related]
53. Withholding 4-methylpyrazole pretreatment in suspected toxic alcohol ingestions.
Ginsburg BY; Anana M; Mayorga O; Hoffman RS
Acad Emerg Med; 2005 Jun; 12(6):575. PubMed ID: 15930414
[No Abstract] [Full Text] [Related]
54. Withholding 4-methylpyrazole pretreatment in suspected toxic alcohol ingestions.
Sivilotti ML; Juurlink DN; Burns MJ
Acad Emerg Med; 2005 Jun; 12(6):574-5. PubMed ID: 15930412
[No Abstract] [Full Text] [Related]
55. The invaders and the barrier.
Pawlotsky JM
J Hepatol; 2012 Jan; 56(1):11-3. PubMed ID: 21925127
[No Abstract] [Full Text] [Related]
56. Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide Analogues.
Konreddy AK; Toyama M; Ito W; Bal C; Baba M; Sharon A
ACS Med Chem Lett; 2014 Mar; 5(3):259-63. PubMed ID: 24900815
[TBL] [Abstract][Full Text] [Related]
57. Expression of Concern: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells.
PLOS ONE Editors
PLoS One; 2022; 17(3):e0266497. PubMed ID: 35358284
[No Abstract] [Full Text] [Related]
58. Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV.
Moghe A; Barve SS; McClain CJ; Joshi-Barve S
Cell Mol Gastroenterol Hepatol; 2018; 5(2):163-164. PubMed ID: 29693044
[No Abstract] [Full Text] [Related]
59. Morphine enhances hepatitis C virus (HCV) replicon expression.
Li Y; Zhang T; Douglas SD; Lai JP; Xiao WD; Pleasure DE; Ho WZ
Am J Pathol; 2003 Sep; 163(3):1167-75. PubMed ID: 12937158
[TBL] [Abstract][Full Text] [Related]
60. Impact of Alcohol on Inflammation, Immunity, Infections, and Extracellular Vesicles in Pathogenesis.
Tharmalingam J; Gangadaran P; Rajendran RL; Ahn BC
Cureus; 2024 Mar; 16(3):e56923. PubMed ID: 38665743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
